Lamivudine treatment in patients with decompensated hepatitis B cirrhosis: For whom and when?

Journal of Hepatology

Volumn 33, Issue 2, 2000, Pages 329-332

  Fontana, R J ^a   Lok, A S F ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; LAMIVUDINE;

CHRONIC HEPATITIS; DRUG EFFICACY; DRUG TOLERABILITY; EDITORIAL; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; LIVER CIRRHOSIS; LIVER FUNCTION; PRIORITY JOURNAL; TREATMENT CONTRAINDICATION; TREATMENT INDICATION;

EID: 0033914448     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(00)80376-1     Document Type: Editorial

References (35)

1. HS Margolis MJ Alter SC Hadler Hepatitis B: evolving epidemiology and implications for control Semin Liver Dis 11 1991 84 92
2. FJ Mahoney Update on diagnosis, management, and prevention of hepatitis B virus infection Clin Microbiol Rev 12 1999 351 366
3. RN Pugh IM Murray-Lyon JL Dawson MC Pietroni R Williams Transection of the esophagus for bleeding esophageal varices Br J Surg 60 1973 646 649
4. E Christensen P Schlichting L Fauerholdt C Gluud PK Anderson E Juhl Prognostic value of Child-Turcotte cirteria in medically treated cirrhosis Hepatology 4 1984 430 435
5. JI Weissberg LL Andres CI Smith S Weick JE Nichols G Garcia Survival in chronic hepatitis B. An analysis of 379 patients Ann Intern Med 101 1984 613 616
6. FE de Jongh HLA Janssen RA de Man WCJ Hop SW Schalm M van Blankenstein Survival and prognostic indicators in hepatitis B surface antigen-positive cirrhosis of the liver Gastroenterology 103 1992 1630 1635
7. F Donato A Tagger R Chiesa ML Ribero V Tomasoni M Fasola Hepatitis B and C virus infection, alcohol drinking, and hepatocellular carcinoma: a case-control study in Italy Hepatology 26 1997 579 584
8. G Fattovich S Boscaro F Novena E Pornaro D Stenico A Alberti Influence of hepatitis Delta virus infection on progression to cirrhosis in chronic hepatitis B J Infect Dis 155 1987 931 935
9. G Realdi G Fattovich S Hadziyannis SW Schalm P Almasio J Sanchez-Tapia Survival and prognostic factors in 366 patients with compensated cirrhosis type B: a multicenter study. The Investigators of the European Concerted Action on Viral Hepatitis (Eurohep) J Hepatol 21 1994 656 666
10. YF Liaw IS Sheen TJ Chen CM Chu CC Pao Incidence, determinants, and significance of delayed clearance of serum HBsAg in chronic hepatitis B virus infection: a prospective study Hepatology 13 1991 627 631
11. WM Lee Hepatitis B virus infection N Engl J Med 337 1997 1733 1745
12. JL Dienstag ER Schiff TL Wright RP Perrillo HL Hann Z Goodman Lamivudine as initial treatment for chronic hepatitis B in the United States N Engl J Med 341 1999 1256 1263
13. C Lai R Chien NWY Leung TT Chang R Guan DI Tai A one year trial of lamivudine for chronic hepatitis B N Engl J Med 339 1998 61 68
14. R Perrillo C Tamburro F Regenstein L Balart H Bodenheimer M Silva Low dose, titratable interferon alfa in decompensated liver disease caused by chronic infection with hepatitis B virus Gastroenterolgy 109 1995 908 916
15. JH Hoofnagle AM DiBisceglie JG Waggoner Y Park Interferon alfa for patients with clinically apparent cirrhosis due to chronic hepatitis B Gastroenterology 104 1993 1116 1121
16. NC Tassopoulos R Volpes G Pastore J Heathcote M Buti RD Goldin Efficacy of lamivudine in patients with hepatitis B e antigen-negative/ hepatitis B virus DNA positive (Precore mutant) chronic hepatitis B Hepatology 29 1999 889 896
17. ER Schiff S Karayalcin I Grimm R Perrillo J Dienstag P Husa A placebo controlled study of lamivudine and interferon alpha-2b in patients with chronic hepatitis B who previously failed interferon therapy Hepatology 28 1998 388A
18. J Villeneuve LD Condreay B Willems G Pomier-Layrargues D Fenyves M Bilodeau Lamivudine treatment for decompensated cirrhosis resulting from chronic hepatitis B Hepatology 31 2000 207 210
19. RP Perrillo ER Schiff JL Dienstag RG Gish RC Dickson PC Adams Lamivudine for suppression of viral replication in patients with decompensated chronic hepatitis B [abstract] Hepatology 30 1999 301A
20. FY Yao NM Bass Lamivudine treatment in patients with severely decompensated cirrhosis due to replicating hepatitis B infection J Hepatol 33 2000 301 307
21. D Kapoor RC Guptan S Wakil SN Kazim R Kaul SR Agarwal Beneficial effects of lamivudine in hepatitis B virus related decompensated cirrhosis J Hepatol 33 2000 308 312
22. RJ Fontana EB Keeffe C Soldevilla L Lilly V Vuketic K Kowdley Is lamivudine beneficial in HBsAg+ patients awaiting liver transplantation? Experience in 182 North American patients [abstract] Transplantation 67 1999 S16
23. NWY Leung CL Lai TT Chang R Guan CM Lee KY Ng Three year lamivudine therapy in chronic HBV [abstract] J Hepatol 30 Suppl 1 1999 59
24. TT Chang CL Lai YF Liaw R Guan SG Lim CM Lee Incremental increases in HBeAg seroconversion and continued ALT normalization in Asian chronic HBV patients treated with lamivudine for four years Antiviral Therapy 5 Suppl. 1 2000 44
25. M Melegari PP Scaglioni JR Wands Hepatitis B virus mutants associated with 3TC and famciclovir administration are replication defective Hepatology 27 1998 628 633
26. P Honkoop HGM Niseters RA deMan AD Osterhaus SW Schalm Lamivudine resistance in immunocompetent chronic hepatitis B J Hepatol 26 1997 1393 1395
27. MM Bartholomew RW Jansen LJ Jeffers KR Reddy LC Johnson H Bunzendahl Hepatitis-B-virus resistance to lamvudine given for recurrent infection after orthotopic liver transplantation Lancet 349 1998 20 22
28. Y Liaw R Chien C Yeh SL Tsai CM Chu Acute exacerbation and hepatitis B virus clearance after emergence of YMDD motif mutation during lamvudine therapy Hepatology 30 1999 567 572
29. D Mutimer D Pillay E Dragon H Tang M Ahmed K O'Donnell High pre-treatment serum hepatitis B virus titre predicts failure of lamivudine prophylaxis and graft re-infection after liver transplantation J Hepatol 30 1999 715 721
30. D Mutimer D Pillay P Cook D Ratcliffe K O'Donnell D Dowling Selection of multiresistant hepatitis B virus during sequential nucleoside-analogue therapy J Infect Dis 181 2000 713 716
31. RA de Man AI Bartholomeusz HG Niester PE Zondervan SA Locarnini The sequential occurrence of viral mutations in a liver transplant recipient re-infected with hepatitis B: hepatitis B immune globulin escape, famiciclovir non-response, followed by lamivudine resistance resulting in graft loss J Hepatol 29 1998 669 675
32. X Xiong C Flores H Yang JJ Toole CS Gibbs Mutations in hepatitis B DNA polymerase with resistance to lamvudine do not confer resistance to adefovir in vitro Hepatology 28 1998 1669 1673
33. R Perrillo ER Schiff A Magill A Murray In vivo demonstration of sensitivity of YMDD mutants to adefovir [abstract] Gastroenterology 116 1999 L0356
34. J Gauthier EJ Bourne MW Lutz LM Crowther JL Dienstag NA Brown Quantitation of hepatitis B viremia and emergence of YMDD variants in patients with chronic hepatitis B treated with lamivudine J Infect Dis 180 1999 1757 1762
35. RP Perrillo J Rakela JL Dienstag G Levy P Martin TL Wright Multicenter study of lamivudine therapy for hepatitis B after liver transplantation Hepatology 29 1999 1581 1586